ATE83237T1 - Pyridinderivate und verfahren zu ihrer herstellung. - Google Patents
Pyridinderivate und verfahren zu ihrer herstellung.Info
- Publication number
- ATE83237T1 ATE83237T1 AT85104723T AT85104723T ATE83237T1 AT E83237 T1 ATE83237 T1 AT E83237T1 AT 85104723 T AT85104723 T AT 85104723T AT 85104723 T AT85104723 T AT 85104723T AT E83237 T1 ATE83237 T1 AT E83237T1
- Authority
- AT
- Austria
- Prior art keywords
- production
- vasodilating
- pyride
- derivatives
- pyride derivatives
- Prior art date
Links
- 230000000304 vasodilatating effect Effects 0.000 abstract 2
- MBELGTLJWJJGLF-UHFFFAOYSA-N 1,4-dihydropyridine-3-carboxylic acid Chemical class OC(=O)C1=CNC=CC1 MBELGTLJWJJGLF-UHFFFAOYSA-N 0.000 abstract 1
- 208000001953 Hypotension Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000021822 hypotensive Diseases 0.000 abstract 1
- 230000001077 hypotensive effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/6574—Esters of oxyacids of phosphorus
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59079560A JPS60248693A (ja) | 1984-04-19 | 1984-04-19 | ピリジン誘導体及び製法 |
EP85104723A EP0159040B1 (de) | 1984-04-19 | 1985-04-18 | Pyridinderivate und Verfahren zu ihrer Herstellung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE83237T1 true ATE83237T1 (de) | 1992-12-15 |
Family
ID=13693390
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT85104723T ATE83237T1 (de) | 1984-04-19 | 1985-04-18 | Pyridinderivate und verfahren zu ihrer herstellung. |
Country Status (15)
Country | Link |
---|---|
US (1) | US5036059A (de) |
EP (1) | EP0159040B1 (de) |
JP (1) | JPS60248693A (de) |
KR (1) | KR850007603A (de) |
AT (1) | ATE83237T1 (de) |
AU (1) | AU570552B2 (de) |
BE (1) | BE902210A (de) |
DE (1) | DE3586879D1 (de) |
ES (1) | ES8606276A1 (de) |
FR (1) | FR2563222B1 (de) |
GB (1) | GB2157695A (de) |
IT (1) | IT1209945B (de) |
NL (1) | NL8500909A (de) |
SE (1) | SE464028B (de) |
ZA (1) | ZA852591B (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6163688A (ja) * | 1984-08-03 | 1986-04-01 | Nissan Chem Ind Ltd | ジヒドロピリジン−5−ホスホン酸環状エステル類 |
CN1016063B (zh) | 1986-01-22 | 1992-04-01 | 日产化学工业株式会社 | 二氢吡啶-5-膦酸环亚丙基酯的制备 |
US4885284A (en) * | 1986-01-22 | 1989-12-05 | Nissan Chemical Industries Ltd. | Dihydropyridine-5-phosphonic acid cyclic propylene ester |
UA5590A1 (uk) * | 1986-01-23 | 1994-12-28 | Ніссан Кемікал Індастріз Лтд | Спосіб одержання пропіленглікового ефіру заміщеної 1,4-дігідропіріділ-5-фосфорної кислоти, або його фармацевтично прийнятной солі або сольвата |
JPS63115890A (ja) * | 1986-10-31 | 1988-05-20 | Nippon Shinyaku Co Ltd | 2位置換1,4−ジヒドロピリジン誘導体 |
JPH01275591A (ja) * | 1988-04-27 | 1989-11-06 | Nissan Chem Ind Ltd | ジヒドロピリジン−5−ホスホン酸誘導体 |
CA1334752C (en) * | 1988-08-02 | 1995-03-14 | Ryozo Sakoda | Drug effect-enhancing agent for antitumor drug |
JP2850376B2 (ja) * | 1988-08-02 | 1999-01-27 | 日産化学工業株式会社 | 抗癌剤薬効増強剤 |
US20020119201A1 (en) * | 2000-09-08 | 2002-08-29 | Novozymes A/S | Lubricated granules |
KR100870527B1 (ko) | 2003-03-28 | 2008-11-26 | 닛산 가가쿠 고교 가부시키 가이샤 | T형 칼슘 채널 저해제 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2094678A5 (de) * | 1970-06-30 | 1972-02-04 | Pepro | |
DE2508181A1 (de) * | 1975-02-26 | 1976-09-09 | Bayer Ag | 1,4-dihydropyridincarbonsaeurearal- kylester, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
JPS59161392A (ja) * | 1983-03-04 | 1984-09-12 | Nippon Shinyaku Co Ltd | ジヒドロピリジン誘導体及びその製法 |
DE3477669D1 (en) * | 1983-09-26 | 1989-05-18 | Nissan Chemical Ind Ltd | Dihydropyridine-5-phosphonic acid cyclic ester |
-
1984
- 1984-04-19 JP JP59079560A patent/JPS60248693A/ja active Granted
-
1985
- 1985-03-25 IT IT8547862A patent/IT1209945B/it active
- 1985-03-26 GB GB08507897A patent/GB2157695A/en not_active Withdrawn
- 1985-03-27 KR KR1019850002009A patent/KR850007603A/ko not_active Application Discontinuation
- 1985-03-28 NL NL8500909A patent/NL8500909A/nl not_active Application Discontinuation
- 1985-04-04 FR FR8505174A patent/FR2563222B1/fr not_active Expired
- 1985-04-04 ZA ZA852591A patent/ZA852591B/xx unknown
- 1985-04-17 SE SE8501882A patent/SE464028B/sv not_active IP Right Cessation
- 1985-04-17 US US06/724,019 patent/US5036059A/en not_active Expired - Fee Related
- 1985-04-17 BE BE0/214853A patent/BE902210A/fr not_active IP Right Cessation
- 1985-04-18 EP EP85104723A patent/EP0159040B1/de not_active Expired - Lifetime
- 1985-04-18 AU AU41405/85A patent/AU570552B2/en not_active Ceased
- 1985-04-18 AT AT85104723T patent/ATE83237T1/de not_active IP Right Cessation
- 1985-04-18 ES ES542378A patent/ES8606276A1/es not_active Expired
- 1985-04-18 DE DE8585104723T patent/DE3586879D1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPS60248693A (ja) | 1985-12-09 |
EP0159040A3 (en) | 1988-08-17 |
ES542378A0 (es) | 1986-04-01 |
IT1209945B (it) | 1989-08-30 |
GB8507897D0 (en) | 1985-05-01 |
FR2563222B1 (fr) | 1989-06-09 |
AU570552B2 (en) | 1988-03-17 |
SE464028B (sv) | 1991-02-25 |
EP0159040B1 (de) | 1992-12-09 |
KR850007603A (ko) | 1985-12-07 |
BE902210A (fr) | 1985-10-17 |
ES8606276A1 (es) | 1986-04-01 |
NL8500909A (nl) | 1985-11-18 |
JPH0259835B2 (de) | 1990-12-13 |
SE8501882L (sv) | 1985-10-20 |
FR2563222A1 (fr) | 1985-10-25 |
AU4140585A (en) | 1985-10-24 |
SE8501882D0 (sv) | 1985-04-17 |
EP0159040A2 (de) | 1985-10-23 |
GB2157695A (en) | 1985-10-30 |
IT8547862A0 (it) | 1985-03-25 |
ZA852591B (en) | 1986-01-29 |
US5036059A (en) | 1991-07-30 |
DE3586879D1 (de) | 1993-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATA195588A (de) | Epipodophyllotoxinglucosid-4'-phosphat-derivate deren herstellung, sowie pharmazeutische zusammensetzungen hierzu | |
ATA912977A (de) | Verfahren zur herstellung von neuen in 2-position substituierten 1,4-dihydropyridin- -derivaten und ihren saeureadditionssalzen | |
ES449162A1 (es) | Un procedimiento para la preparacion de un compuesto racemi-co u 8r-antimerico. | |
DE3888217D1 (de) | Supraleitende Zusammensetzungen und Verfahren zu deren Herstellung. | |
DE3784401D1 (de) | Karbostyril-derivate und ihre salze, verfahren zu ihrer herstellung und diese enthaltende kardiotonische zusammensetzung. | |
ATE83237T1 (de) | Pyridinderivate und verfahren zu ihrer herstellung. | |
DE2967701D1 (de) | A-21978 genannte antibiotische mischung, verfahren zu ihrer herstellung, ihre pharmazeutischen zusammensetzungen und produzierender mikroorganismus. | |
ATE50571T1 (de) | Dihydropyridin-carbonsaeureamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln. | |
AT340926B (de) | Verfahren zur herstellung von neuen, basisch substituierten 1,4-dihydro-2h-isochinolinderivaten sowie deren salzen | |
DE3482258D1 (de) | 2,2-difluorpropionsaeurederivate und verfahren zu ihrer herstellung. | |
ATA328587A (de) | Neue furanuronsaeure-derivate, verfahren zu deren herstellung und sie enthaltende therapeutische zusammensetzungen | |
DE3574706D1 (de) | Chartreusin-derivate, ihre salze, antitumorale zusammensetzungen und verfahren zu ihrer herstellung. | |
FR2347381A1 (fr) | Nouveaux derives d'anthracycline-glycosides, en particulier designes sous le nom d'antibiotiques ma 144-m1 et ma 144-m2, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits composes comme agents antitumeurs | |
ATE37369T1 (de) | Eine thiazinverbindung, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
DE3586817D1 (de) | 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
JPS5536484A (en) | Novel 1*44dihydropyridazinee33carboxylic acid derivative | |
ATA765977A (de) | Verfahren zur herstellung von neuen 3-aminomethyl-2-phenyl-bicyclo (2,2,2) octanen und -octenen sowie deren saureadditionssalzen | |
ATE24711T1 (de) | Bicyclo(3.2.1)octancarbonsaeure-derivate, verfahren zu ihren herstellung und ihre therapeutische verwendung. | |
ATE103899T1 (de) | Zwischenprodukte und verfahren zu ihrer herstellung. | |
ATA559778A (de) | Verfahren zur herstellung von neuen 1,2- -benzisothiazolen und deren saeureadditions- salzen | |
DE2924522A1 (de) | Phenanthrenderivate, verfahren zu deren herstellung sowie die phenanthrenderivate enthaltenden pharmazeutischen zusammensetzungen | |
ATE2520T1 (de) | Dihydronicotinsaeurederivate und deren herstellung sowie verwendung. | |
ATA134577A (de) | Verfahren zur herstellung von 9,10- dihydroergosin und dessen physiologisch bertraeglichen saeureadditionssalzen | |
AT352136B (de) | Verfahren zur herstellung von neuen 1,5,10,10a- tetrahydrothiazolo-(3,4-b) -isochinolin-derivaten und von deren saeure- additionssalzen | |
BE830576A (fr) | Derives actifs d'acetoxime, compositions therapeutiques les contenant ainsi que les procedes de preparation de ces derives et compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REN | Ceased due to non-payment of the annual fee |